Dr. Yip Pui Lun - Haematology & Haematological Oncology
Specialist in Haematology & Haematological Oncology
Highlights
- MCHK RegisteredVerified
- Specialist in Haematology & Haematological OncologyBachelor of Medicine and Bachelor of Surgery (MBChB) · Hong Kong College of Physicians · Medical degree 2010
- InsuranceBeing compiled｜See details
About
Dr. Yip Pui Lun is a registered Haematology & Haematological Oncology specialist in Hong Kong.
Education
Specialist in Haematology & Haematological Oncology
- Bachelor of Medicine and Bachelor of Surgery (MBChB)Bachelor of Medicine and Bachelor of Surgery (MBChB)2010
Hong Kong Academy of Medicine fellowships
- FHKCPFellow, Hong Kong College of Physicians
Source: Hong Kong Academy of Medicine Fellows Register, checked 12 Sep 2026
Insurance
Insurance plans being compiled
We're collecting insurance plan data per clinic. For confirmation, contact the clinic directly.
Are you Dr. Yip Pui Lun? Claim page and update insurance →
FAQ
Is Dr. Yip Pui Lun any good?
Dr. Yip Pui Lun is a registered Haematology & Haematological Oncology specialist in Hong Kong. Qualifications and registration come from the Hong Kong Medical Council. ok.med does not rate or rank doctors.
What does Dr. Yip Pui Lun do?
Dr. Yip Pui Lun practises in Haematology & Haematological Oncology.
Are you Dr. Yip Pui Lun? Claim this page to update and manage.
ClaimResearch and publications
6 papers
Filter by paper topic
Topics come from medical classifications on these PubMed papers, not from the doctor's listed services.
- Kidney Injury Associated with Monoclonal Gammopathy: A Nephrologist's Perspective.Kidney360 · 2026
- The clinical utility of the HFA-ICOS risk proforma for predicting heart failure hospitalization in a real-world cohort of multiple myeloma patients.BMC cardiovascular disorders · 2026
- Lupus anticoagulant associated with low grade B-cell lymphoma and IgM paraproteinaemia with lupus cofactor phenomenon on DRVVT and SCT assays - a possible novel association.Thrombosis journal · 2024
- Temozolomide showed rapid activity in a patient with refractory CNS monomorphic epitheliotropic T cell lymphoma.Annals of hematology · 2021
- Venetoclax monotherapy induced rapid and sustained response in a frail patient with refractory AL amyloidosis: Less is more?International journal of hematology · 2020
- Severe Bleeding Tendency due to Excessive Fibrinolysis in Two Patients With Aortic Disease: Role of Tranexamic Acid in Non-Surgical Candidate.Journal of medical cases · 2020
Publication data comes from PubMed / Europe PMC and is matched automatically by name and affiliation. Every entry links to the source.
For reference only. Not medical advice. Read full disclaimer